Search PubMed⌕ Search

Biomedical subjects

J J Marchalonis

Publications and source records attributed to J J Marchalonis.

241 records · Page 14Linked to original sources

Evolutionary perspectives on amyloid and inflammatory features of Alzheimer disease.

We propose that the amyloid deposits in senile plaques of Alzheimer's Disease (AD) result from ancient mechanisms in wound-healing and inflammatory processes that preceded the evolution of the inducible combinatorial immune responses characteristic of jawed vertebrates. AD plaques are unlike active plaques in MS, because antibodies, T-cells and, B cells are not conspicuous components of senile plaques or other loci of degeneration. However, senile plaques contain amyloids and other inflammatory proteins of ancient origin that appear to be made by local brain cells, including neurons, astrocytes, and microglia. We describe a highly conserved 16-mer found in pentrakins from mammals and from the horseshoe crab. The senile plaque thus provides a novel opportunity to study primitive features of complement-mediated inflammatory responses in the absence of immunoglobulins.

Alzheimer Disease↗

Shared antigenic determinants of immunoglobulins in phylogeny and in comparison with T-cell receptors.

1. Immunoglobulins are a complex multigene family of proteins specified by genes encoding variable (V), sometimes diversity (D), joining (J), and constant (C) domains. 2. Cross-reactions involving conformational determinants related to the VHa system of rabbits occur on heavy chains of vertebrate species ranging from elasmobranchs to man. 3. Serological markers characteristic of mu chains, the heavy chain of the IgM macroglobulins, occur on homologous heavy chains of species representing all vertebrate classes. 4. Serological markers characteristic of gamma type heavy chains, the major isotype in man, are restricted to the mammals, but are found on representatives of even the most primitive mammals, the egg-laying monotremes. 5. Variable region markers characteristic of lambda light chains are shared by light chains of shark and man. 6. Certain idiotypic markers defined by combining site V region sequences are broadly distributed in evolution. 7. Use of synthetic peptides as antigens and in epitope mapping show that amino acid sequences from the third framework region of the variable domain are broadly shared among light chain in phylogeny and between light chains and T-cell receptor beta chains. 8. The "switch peptides" linking the V and C domains of light chains and T-cell receptors, specified by the C-terminal portion of the J segment and the N-terminus of the constant region, are exposed in the three-dimensional structure of immunoglobulin or Tcrs, show striking homology, and form broadly shared antigenic determinants characteristic of immunoglobulins. 9. Although the multigene nature of the immunoglobulins and the complexity of antigenic determinants expressed by these large proteins renders comparison among molecules difficult, serum immunoglobulins and the closely related T-cell receptors express numerous shared determinants defined on the basis of amino acid sequence homology and three-dimensional conformations.

Amino Acid Sequence↗

Biochemical characterization of human Thy-1.

The human Thy-1 homologue (p25) was characterized biochemically for amino acid composition, sequence and carbohydrate content. Two other forms of the human Thy-1 molecule were detected and partially characterized. A 40,000 mol.wt. molecule (p40) is the dimer of p25 and its formation is increased by the presence of sodium dodecyl sulphate (SDS). The second form of 16,000 mol.wt. (p16) appears to be a cryptic or breakdown form of p25. Comparison of the amino acid compositions of p25, p40 and p16 isolated from MOLT-3 cells, with that deduced from the nucleotide sequence of the gene coding for part of the putative T cell antigen receptor, also from MOLT-3 cells, shows that the Thy-1 homologue is distinct from, but evolutionary related to, one of the putative T cell antigen receptor polypeptide chains.

Amino Acids↗

Epitope promiscuity of human monoclonal autoantibodies to T-cell receptor-combining site determinants.

To characterize the binding specificity and light- and heavy-chain variable region usage in monoclonal human autoantibodies (mAAbs) to T-cell receptors, we constructed heterohybridomas from peripheral blood B cells of three rheumatoid arthritis (RA) patients. From a panel of more than 200 heterohybridomas secreting IgM autoantibodies binding to T-cell receptor Vbeta chain first complementarity determining segments (CDR1), we characterized two IgM/lambda molecules from a single patient in detail. These bound to both CDR1 peptide epitopes and intact TCR of recombinant single-chain T-cell receptor constructs, and to T-cell surface TCR. Spectratype analysis using epitopes mimicking a set of 24 Vbeta genes indicated that one molecule bound only a few members of the set, whereas the second showed considerable epitope promiscuity by binding to more than half of the tested CDR1 peptides. Both mAAbs used variants of a Vlambda3 gene that were very similar to one another and to the germline gene. The epitope-promiscuous autoantibody used a V(H)4 gene identical to a germline prototype, while the other incorporated a V(H)3 sequence differing in only a single residue from its germline prototype. The CDR3s of both were large and distinct from each other as well as from the corresponding segments of rheumatoid factors and "cold agglutinins" using the same or related V(H) germline genes. These mAAbs offer models for deciphering the basis of epitope promiscuity, and serve as candidates for direct use in immunomodulation because they are of intrinsic human origin and do not require molecular engineering to adapt them for use in therapy.

Amino Acid Sequence↗

Antigen recognition by T lymphocytes (status of the minimal hypothesis).

Data of recent studies based upon three approaches to the problem of the T cell receptor for antigen, namely, use of "anti-receptor" (= anti-idiotype) antibodies, utilization of antisera made against circulating antibodies in association with physiochemical characterization procedures, and phylogenetic investigations, support the conclusion that this recognition molecule is an immunoglobulin, but that it represents as isotype distinct from usual circulating antibodies and B cell surface IgM- and IgD-like molecules.

Antibodies↗

The kinetics of cytokine secretion and proliferation by mesenteric lymph node cells during the progression to murine AIDS, caused by LP-BM5 murine leukemia virus infection.

A murine acquired immunodeficiency syndrome (MAIDS) is induced in genetically susceptible strains of mice inoculated with LP-BM5 murine leukemia virus. It is characterized by progressive lymphoproliferation, profound immunodeficiency, and the subsequent loss of resistance to opportunistic pathogens, including intestinal pathogens. Cellular and/or humoral immunity of gut-associated lymphoid tissues may play a key role in the elimination of these pathogens. We have previously demonstrated reductions in the number of mucosal T and B cells in MAIDS. In this study, the cytokine production by mesenteric lymph nodes (MLN) cells and their proliferative response to mitogens during MAIDS were investigated. Alterations were observed in the kinetics of MLN cell proliferation and cytokine secretion by in vitro mitogen-stimulated MLN cells during the retrovirus infection. Cytokine production was abnormally changed, with a gradual decrease in interleukin-2 (IL-2) production as well as an increase in IL-5 and IL-6 secretion. Interferon-gamma production was increased during the progression to MAIDS. The dysregulated release of cytokines by MLN cells due to retrovirus infection could lead to immune dysfunction. These data indicate that dysregulated cytokine secretion by MLN cells may be responsible for impaired mucosal immunity in AIDS, explaining the dramatic increase of opportunistic intestinal pathogens in individuals with AIDS.

Animals↗